Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model

Yüce M., Albayrak E.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY , cilt.196, sa.7, ss.4105-4124, 2024 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 2
  • Captures
    • Readers: 2
see details

MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis

MERİÇ N., Albayrak E., Gulbas Z., Kocabas F.
LEUKEMIA & LYMPHOMA , cilt.65, sa.2, ss.187-198, 2024 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 6
  • Captures
    • Readers: 3
see details

Hyperthermia-stimulated tonsil-mesenchymal stromal cells suppress hematological cancer cells through downregulation of IL-6

Yüce M., Albayrak E.
JOURNAL OF CELLULAR BIOCHEMISTRY , cilt.123, sa.12, ss.1966-1979, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 2
  • Captures
    • Readers: 8
see details

BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability

Albayrak E., Akgol S., Turan R. D., Uslu M., Kocabas F.
Journal of Cellular Biochemistry , cilt.123, sa.12, ss.2009-2029, 2022 (SCI-Expanded) identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 3
  • Captures
    • Readers: 7
see details

Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content

Uslu M., Albayrak E., KOCABAŞ F.
INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.110, 2022 (SCI-Expanded) identifier identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 3
  • Captures
    • Readers: 5
see details

Small molecule-mediated modulation of ubiquitination and neddylation improves HSC function ex vivo

Albayrak E., Uslu M., Akgol S., Tuysuz E. C., Kocabas F.
Journal of Cellular Physiology , cilt.236, sa.12, ss.8122-8136, 2021 (SCI-Expanded) identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 9
  • Captures
    • Readers: 5
  • Social Media
    • Shares, Likes & Comments: 43
see details

Development of Small Molecule MEIS Inhibitors that modulate HSC activity

Turan R. D., Albayrak E., Uslu M., Siyah P., Alyazici L. Y., Kalkan B. M., et al.
Scientific Reports , cilt.10, sa.1, 2020 (SCI-Expanded) Creative Commons License identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 26
  • Captures
    • Readers: 55
  • Social Media
    • Shares, Likes & Comments: 9
see details

Temporal modulation of calcium sensing in hematopoietic stem cells is crucial for proper stem cell expansion and engraftment

Uslu M., Albayrak E., Kocabaş F.
Journal of Cellular Physiology , cilt.235, sa.12, ss.9644-9666, 2020 (SCI-Expanded) identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 23
  • Captures
    • Readers: 20
see details

c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression

Aksoz M., Albayrak E., Aslan G. S., Turan R. D., Alyazici L. Y., Siyah P., et al.
Current Cancer Drug Targets , cilt.19, sa.6, ss.479-494, 2019 (SCI-Expanded) identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 23
  • Captures
    • Readers: 33
  • Social Media
    • Shares, Likes & Comments: 141
see details

Emerging roles of meis1 in cardiac regeneration, stem cells and cancer

Aksöz M., Turan R. D., Albayrak E., Kocabaş F.
Current Drug Targets , cilt.19, sa.2, ss.181-190, 2018 (SCI-Expanded) Creative Commons License identifier identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Patent Family Citations: 1
    • Citation Indexes: 34
  • Captures
    • Readers: 40
see details
Diğer Dergilerde Yayınlanan Makaleler

Tonsil mesenchymal stem cells-derived exosomes differentially effect the cell proliferation depending on different temperature conditions

YÜCE M., ŞİŞLİ İ., ÇİFTCİOĞLU E., ALBAYRAK E., KIRBAŞ O. K., TAŞLI P. N., et al.
The European Research Journal , cilt.10, sa.5, ss.501-512, 2024 (Hakemli Dergi) identifier

Changes in stemness properties of human adenoid-derived mesenchymal stem cells during in vitro aging

Yuce M., Albayrak E., Akgül G., Yağcı N., Tekcan E.
Frontiers in Life Sciences and Related Technologies (Online) , cilt.5, sa.2, ss.122-129, 2024 (Hakemli Dergi) identifier

Conditioned media of tonsil derived mesenchymal stem cells shows different rates of cytotoxicity on solid cancer cells

YÜCE M., ALBAYRAK E., GÜMÜŞKAPTAN Ç.
Anatolian Current Medical Journal , cilt.5, sa.4, ss.503-510, 2023 (Hakemli Dergi)

CRISPR/Cas9 system in hematopoietic stem cells: Basic research and clinical applications

Albayrak E.
Journal of Experimental and Clinical Medicine (Turkey) , cilt.40, sa.1, ss.161-170, 2023 (Scopus) Creative Commons License identifier
Plum Print visual indicator of research metrics
PlumX Metrics
  • Captures
    • Readers: 4
see details

Mesenchymal Stem Cell Applications for the Treatment of COVID-19: Clinical Perspective

Kasaplı B. N., Duran Ş. Y., Geçit T., Albayrak E., Yüce M.
ClinMed International Library , cilt.9, 2022 (Hakemli Dergi)
Plum Print visual indicator of research metrics
PlumX Metrics
  • Captures
    • Readers: 2
see details
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

Kronik Miyeloid Lösemide CRISPR/Cas9 Aracılı Yeni Nesil Gen Tedavisi

SOMUNCU M. N., YILDIRIM S., AYDIN C., ZAMANİ A. G., ALBAYRAK E., KAVAKLI İ. H.
1.ulusal Hematoonkogenetik Kongresi, 25 Kasım 2021

Kronik Miyeloid Lösemide Crispr/cas9 Aracılı Yeni Nesil Gen Tedavisi

SOMUNCU M. N., YILDIRIM M. S., AYDIN C., ZAMANİ A. G., ALBAYRAK E., KAVAKLI İ. H.
“1. Ulusal HematoOnkoGenetik Kongresi”, Antalya, Türkiye, 25 Kasım 2021, ss.129-130

Lösemi Kök Hücrelerinde MEİS1 İfade Profilinin Belirlenmesi Ve MEİS1 İnhibitörlerin Etkisinin İncelenmesi

MERİÇ N., ALBAYRAK E., KOCABAŞ F., GÜLBAŞ Z.
47.Ulusal Hematoloji Kongresi, Antalya, Türkiye, 4 - 07 Kasım 2021, ss.252

Role of Sialyltransferase Family in Cardiomyocyte and Hematopoietic Stem Cell Function

ALBAYRAK E., KOCABAŞ F.
2nd International Stem Cell Congress, Türkiye, 15 Ekim 2015
Kitaplar

Therapeutic targeting and HSC proliferation by small molecules and biologicals

Albayrak E., Kocabaş F.
Control of Cell Cycle & Cell Proliferation, Rossen Donev, Editör, Elsevier Science, Oxford/Amsterdam , Oxford, ss.425-496, 2023

Kara Mürver ve Kanser

Albayrak E., Yüce M., Gümüşkaptan Ç.
Kara Mürver: Meyve mi İlaç mı?, Hayrettin Mutlu,Elif Günalan, Editör, Nobel Yayınevi, Ankara, ss.117-146, 2022
Metrikler

Yayın

21

Atıf (WoS)

4

H-İndeks (WoS)

2

Atıf (Scopus)

127

H-İndeks (Scopus)

6

Proje

11

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları